Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Immunological Medicines for Poultry

Immunological veterinary medicinal products, including vaccines, are authorised for poultry.

Search results 101 to 125 from a total of 134

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date An­i­mal Further Information

Vectormune ND

Marek'sche Krankheit, Newcastle-Krankheit

CEVA-Phylaxia Co. Ltd., Ungarn

EU/2/15/188 08.09.2015 Huhn

EPAR: Vectormune ND

Vectormune FP ILT + AE

Hühnerpocken, Aviäre Infektiöse Laryngotracheitis, Aviäre Enzephalomyelitis

CEVA-Phylaxia Co. Ltd., Ungarn

EU/2/20/250 24.04.2020 Huhn

Vectormune FP ILT

Hühnerpocken, Infektiöse Laryngotracheitis

Ceva-Phylaxia Co. Ltd., Ungarn

EU/2/20/266 09.12.2020 Huhn

Ultifend ND IBD

Newcastle-Krankheit, Infektiöse Bursitis, Marek'sche Krankheit

Ceva-Phylaxia Co. Ltd., Ungarn

EU/2/21/272 20.04.2021 Huhn

Newflend ND H9

Newcastle-Krankheit, Aviäre Influenza

Ceva-Phylaxia Co. Ltd., Ungarn

EU/2/23/296 16.05.2023 Huhn

EPAR: Newflend ND H9

Cevac Salmune ETI K

Salmonellen-Infektion

Ceva-Phylaxia Co. Ltd., Ungarn

EU/2/24/320 02.09.2024 Huhn

EPAR: Cevac Salmune ETI K

CEVAC IBird

Infektiöse Bronchitis

Ceva Tiergesundheit GmbH

PEI.V.11646.01.1 20.06.2013 Huhn

Cevac Salmovac

Salmonellen-Infektion

Ceva Tiergesundheit GmbH

PEI.V.02823.01.1 07.11.2002 Huhn

Cevac Meta L

Aviäre Rhinotracheitis

Ceva Tiergesundheit GmbH

PEI.V.11806.01.1 31.10.2016 Huhn

CEVAC TRANSMUNE

Infektiöse Bursitis

Ceva Tiergesundheit GmbH

PEI.V.11421.01.1 15.10.2010 Huhn

Novamune

Infektiöse Bursitis

CEVA Tiergesundheit GmbH

PEI.V.11907.01.1 14.08.2018 Huhn

CEVAC MASS L

Infektiöse Bronchitis

Ceva Tiergesundheit GmbH

PEI.V.11823.01.1 04.04.2016 Huhn

Vaxxitek HVT + IBD

Infektiöse Bursitis,
Marek'sche Krankheit

Boehringer Ingelheim Vetmedica GmbH

EU/2/02/032/001 13.08.2002 Huhn

EPAR: Vaxxitek HVT + IBD

Avinew

Newcastle-Krankheit

Boehringer Ingelheim Vetmedica GmbH

PEI.V.02053.01.1 05.03.2002 Huhn

Avinew NEO

Newcastle-Krankheit

Boehringer Ingelheim Vetmedica GmbH

PEI.V.02053.02.1 30.07.2020 Huhn, Pute

Dindoral SPF

Infektiöse Hämorrhagische Enteritis

Boehringer Ingelheim Vetmedica GmbH

5a/95 22.07.1996 Pute

Terivac

Infektiöse Rhinotracheitis

Boehringer Ingelheim Vetmedica GmbH

106a/90 18.11.1998 Pute

Gallimune 407 ND+IB+EDS+ART

Newcastle-Krankheit, Infektiöse Bronchitis, Egg Drop-Syndrom, Aviäre Rhinotracheitis

Boehringer Ingelheim Vetmedica GmbH

PEI.V.01043.01.1 11.05.2000 Huhn

Parvokan

Parvovirose der Moschusenten,
Derzsysche Krankheit

Boehringer Ingelheim Vetmedica GmbH

PEI.V.01012.01.1 06.05.2004 Moschusente

Palmivax

Parvovirushepatitis

Boehringer Ingelheim Vetmedica GmbH

44a/83 21.06.2000 Gans, Moschusente

Trituren

Newcastle Disease,
Paramyxovirose der Pute,
Infektiöse Rhinotracheitis

Boehringer Ingelheim Vetmedica GmbH

38a/92 27.12.1994 Pute

Gallimune 303 ND+IB+ART

Newcastle-Krankheit, Infektiöse Bronchitis, Aviäre Rhinotracheitis

Boehringer Ingelheim Vetmedica GmbH

PEI.V.01041.01.1 15.05.2000 Huhn

HatchPak Avinew

Newcastle-Krankheit

Boehringer Ingelheim Vetmedica GmbH

PEI.V.03614.01.1 27.05.2008 Huhn

Gallimune 302 ND+IB+EDS

Newcastle-Krankheit, Infektiöse Bronchitis, Egg Drop-Syndrom

Boehringer Ingelheim Vetmedica GmbH

PEI.V.01042.01.1 15.05.2000 Huhn

Gallimune Se + St

Salmonellen-Infektion

Boehringer Ingelheim Vetmedica GmbH

PEI.V.03348.01.1 15.06.2007 Huhn

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 528 in BAnz AT 25.04.2025 B4.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 25.04.2025